Prolight Diagnostics

Fund · SE0003618230 (XSTO)

Overview

No Price

n/a

Share Float & Liquidity

Free Float -

Shares Float -

Shares Outstanding 12,04 M

Company Profile for Prolight Diagnostics Fund

Prolight Diagnostics AB develops patient-based test systems based on patented technology. It offers integrated diagnostic support consisting of handy measuring instruments and disposable chips for diagnosis of heart attacks and also for long-term evaluation of the risks for heart disease. The company was founded by Masoud Khayyami in 1999 and is headquartered in Lund, Sweden.

Get up to date insights from finAgent about Prolight Diagnostics

Company Data

Name Prolight Diagnostics

Company Prolight Diagnostics

Website http://www.pldab.com

Primary Exchange

NASDAQ STOCKHOLM AB

ISIN SE0003618230

Asset Class Fund

Sector Healthcare

Industry Medical - Specialties

CEO Ulf Bladin

Market Capitalization 276 Mio

Country Sweden

Currency SEK

Employees -

Address , Lund

IPO Date 2017-03-31

Stock Splits

Date	Split
10.12.2025	1:100

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	PRLD.ST

More Shares

Investors who hold Prolight Diagnostics also have the following shares in their portfolio:

Crestchem Limited Share

WRT LKD ORD SHS YANTAI SHUANGTA 09/01/25 Verbriefte Derivate

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog